Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Lecture notes in networks and systems

Drug Discovery Using Variational Quantum EigenSolver

S. Surya Prakash, P. Banu Priya, Sudarshan Someneni, Udendhran, Arnab Banerjee

Published Jan 1, 2025• 2 citations
Publisher
DOI
10.1007/978-981-96-3942-7_51

Related papers

Quantum–Classical Neural Networks with Variational Circuits for Molecular Docking in Drug Discovery

K. Kalaiselvi, G. Husna Khouser, Kavitha A K +3 more

International Conference on Cognitive Computing and Networking Systems (ICC-CNS)•Jun 1, 2026•0 citations

Hybrid Quantum-Classical Algorithms for Drug Discovery and Molecular Simulation

Murali Krishna Pasupuleti

Abstract: This study explores the implementation of hybrid quantum-classical algorithms in the realm of drug discovery and molecular simulation, with an emphasis on optimizing molecular interaction prediction. The integration of quantum computing paradigms, particularly the Variational Quantum Eigensolver (VQE), with classical machine learning techniques is evaluated for its efficacy in simulating molecular systems. Key results demonstrate superior accuracy in predicting binding affinities and reaction energetics using the hybrid models compared to traditional methods. The findings offer significant implications for accelerating the drug development pipeline, particularly in early-stage candidate screening. Keywords: Hybrid computing, Quantum simulation, Molecular interaction, Drug discovery, Variational Quantum Eigensolver, Quantum-classical integration

International Journal of Academic and Industrial Research Innovations(IJAIRI)•Jun 27, 2025•1 citation

Computing static molecular properties using variational quantum eigensolver

Wataru Mizukami, Kosuke Mitarai, Nakagawa Yuya

日本物理学会講演概要集•Jan 1, 2020•0 citations

Variational Quantum Eigensolver and Its Applications

Atsushi Matsuo

Lecture notes in computer science•Jan 1, 2021•1 citation

Quantum Algorithms for Drug Discovery and Molecular Simulation

Marta Ivanov, Nina Muller, Oscar Hansen

Drug discovery and molecular simulation are among the most promising near-term application domains for quantum computing, where electronic structure calculations -- scaling exponentially on classical computers via full configuration interaction -- become tractable through quantum phase estimation and variational quantum eigensolver (VQE) algorithms. This paper proposes the Quantum Drug Discovery Framework (QDDF), evaluating six quantum algorithms -- VQE, ADAPT-VQE, quantum phase estimation (QPE), quantum Monte Carlo (QMC), quantum machine learning for molecular property prediction, and quantum generative models for de novo drug design -- across 20 molecular benchmarks spanning H2 through FeMoco (54 qubits). Key results: ADAPT-VQE achieves chemical accuracy (< 1 kcal/mol) for molecules up to 24 qubits on NISQ hardware; QPE reaches ground-state energy error < 0.1 mHa for H2O on fault-tolerant models; quantum ML reduces molecular property prediction error by 22.4% versus classical graph neural networks. The framework introduces the Quantum Drug Discovery Utility Score (QDDUS) and quantum advantage thresholds for each task.

Quantum Frontiers Journal•Nov 12, 2025•0 citations

Quantum Assisted Drug Discovery in Human Beings

B S Anupama, Amrit S R, A Chetan Kumar

The large search space and the challenge of accurately simulating quantum-level molecular interactions are the fundamental causes of the delayed, complicated, and costly process of discovering new medications. The effectiveness of conventional computational techniques, including molecular docking and molecular dynamics, to assess molecular characteristics and provide highly accurate drug candidate predictions is constrained. This paper presents a Quantum-Assisted Drug Discovery Simulation framework that combines cutting-edge quantum computing algorithms, specifically the Quantum Approximate Optimization Algorithm (QAOA) and the Variational Quantum Eigensolver (VQE), with traditional molecular docking tools like RDKit and AutoDock. The system uses these quantum algorithms to perform very accurate Quantum Refinement on the most potential therapeutic protein poses found by classical identification. This hybrid approach seeks to optimize drug-protein interactions more quickly, speed up early-stage drug discovery, and create opportunities for less costly, more accurate medical research, even though a combination of quantum and classical calculations allows more accurate prediction of molecular energies and binding affinities.

International Conference on Knowledge Engineering and Communication Systems (ICKECS)•Apr 24, 2026•0 citations
Abstract: This study explores the implementation of hybrid quantum-classical algorithms in the realm of drug discovery and molecular simulation, with an emphasis on optimizing molecular interaction prediction. The integration of quantum computing paradigms, particularly the Variational Quantum Eigensolver (VQE), with classical machine learning techniques is evaluated for its efficacy in simulating molecular systems. Key results demonstrate superior accuracy in predicting binding affinities and reaction energetics using the hybrid models compared to traditional methods. The findings offer significant implications for accelerating the drug development pipeline, particularly in early-stage candidate screening. Keywords: Hybrid computing, Quantum simulation, Molecular interaction, Drug discovery, Variational Quantum Eigensolver, Quantum-classical integration
Drug discovery and molecular simulation are among the most promising near-term application domains for quantum computing, where electronic structure calculations -- scaling exponentially on classical computers via full configuration interaction -- become tractable through quantum phase estimation and variational quantum eigensolver (VQE) algorithms. This paper proposes the Quantum Drug Discovery Framework (QDDF), evaluating six quantum algorithms -- VQE, ADAPT-VQE, quantum phase estimation (QPE), quantum Monte Carlo (QMC), quantum machine learning for molecular property prediction, and quantum generative models for de novo drug design -- across 20 molecular benchmarks spanning H2 through FeMoco (54 qubits). Key results: ADAPT-VQE achieves chemical accuracy (< 1 kcal/mol) for molecules up to 24 qubits on NISQ hardware; QPE reaches ground-state energy error < 0.1 mHa for H2O on fault-tolerant models; quantum ML reduces molecular property prediction error by 22.4% versus classical graph neural networks. The framework introduces the Quantum Drug Discovery Utility Score (QDDUS) and quantum advantage thresholds for each task.
The large search space and the challenge of accurately simulating quantum-level molecular interactions are the fundamental causes of the delayed, complicated, and costly process of discovering new medications. The effectiveness of conventional computational techniques, including molecular docking and molecular dynamics, to assess molecular characteristics and provide highly accurate drug candidate predictions is constrained. This paper presents a Quantum-Assisted Drug Discovery Simulation framework that combines cutting-edge quantum computing algorithms, specifically the Quantum Approximate Optimization Algorithm (QAOA) and the Variational Quantum Eigensolver (VQE), with traditional molecular docking tools like RDKit and AutoDock. The system uses these quantum algorithms to perform very accurate Quantum Refinement on the most potential therapeutic protein poses found by classical identification. This hybrid approach seeks to optimize drug-protein interactions more quickly, speed up early-stage drug discovery, and create opportunities for less costly, more accurate medical research, even though a combination of quantum and classical calculations allows more accurate prediction of molecular energies and binding affinities.